SCHEMBL14135157

SCHEMBL14135157

C=C1C=C(F)C(F)=CC1=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18197738 0.56 — —
SCHEMBL5052796 0.50 — —
SCHEMBL19561629 0.48 — —
SCHEMBL10044093 0.46 — —
SCHEMBL9406865 0.42 — —
SCHEMBL2053378 0.40 — —
SCHEMBL2136863 0.38 — —
SCHEMBL321045 0.37 — —
SCHEMBL148004 0.34 — —
SCHEMBL1482242 0.34 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1956020-A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity SMITHKLINE BEECHAM PLC (GB) 2008-08-13 — — EP disclosed
EP-1385845-B1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM PLC (GB) 2008-01-09 — — EP disclosed
Send feedback